Locals walk to find cure for rare autoimmune disease
About 150 people took part in the 22nd annual Stepping Out to Cure Scleroderma Walk at Boardman Park. The walk is hosted by the Lower Great Lakes Chapter of the National Scleroderma Foundation.
It's the chapter's biggest event of the year to raise money and awareness for the disease.
'It's a rare autoimmune disease, and there are many different cases and journeys. Everyone's journey is different, and what it does — there's two different cases. It can attack the internal organs and also your skin as well,' said Dionna Bartos, executive director for the Lower Great Lakes Chapter of the National Scleroderma Foundation.
The money raised through the walk will go to advance medical research, promote awareness of scleroderma and provide support for patients and their families.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
3 minutes ago
- Associated Press
Shaping the next decade of musculoskeletal care: MSK Business Summit launches in Scottsdale
Surgeons, executives, and industry innovators invited to unite and tackle workforce challenges, value-based care, and the technologies transforming orthopedic practices PHOENIX, Aug. 21, 2025 /PRNewswire/ -- The MORE Foundation, a nonprofit dedicated to advancing musculoskeletal health through research, education, and community outreach, proudly announces the launch of the First Annual Musculoskeletal (MSK) Business Summit. This two-day event will take place at the Talking Stick Resort in Scottsdale, Arizona, bringing together a dynamic mix of surgeons, executives, payors, physical therapy leaders, and medical device professionals for an immersive exploration of the future of musculoskeletal (MSK) business and care delivery. The musculoskeletal industry is undergoing rapid transformation, with shifting reimbursement models, new technologies, workforce challenges, and heightened patient expectations. The MSK Business Summit was created to provide a platform where leaders from across the spectrum can connect, share solutions, and develop actionable strategies for success in this new environment. Attendees will have the opportunity to earn up to 12 AMA PRA Category 1 Credits™, while engaging in: This year's event will be co-chaired by two of the most respected names in the musculoskeletal healthcare industry: Dr. Ast said, 'Healthcare is changing faster than ever before, and musculoskeletal care is at the forefront of that evolution. Our goal is to ensure attendees walk away with actionable strategies - whether it's leveraging new technologies, optimizing operations, or building sustainable care models - that can be implemented immediately within their organizations.' In addition to its robust educational programming, the MSK Business Summit will provide unparalleled networking opportunities. Attendees will connect with peers, industry innovators, and decision-makers in an environment designed for collaboration. Whether during structured networking sessions or informal gatherings at the resort, these connections are intended to spark partnerships and initiatives that will shape the future of MSK care. 'The MSK Business Summit is more than just another conference. It's a catalyst for transformation,' said Dr. Meneghini. 'I'm honored to be part of an event that brings together diverse people and ideas, creating a space where clinical excellence meets business innovation, and where leaders from across the musculoskeletal world can collaborate to shape the next decade of patient care.' Talking Stick Resort, nestled in the stunning Sonoran Desert, offers the perfect backdrop for professional growth and rejuvenation. In addition to the MSK Business Summit, attendees can enjoy the resort's luxury accommodations, award-winning dining, spa services, golf, and nearby cultural attractions, making the Summit both a valuable professional experience and a memorable getaway. Registration and Details For more information and to register for the MSK Business Summit, visit About The MORE Foundation The MORE Foundation (Musculoskeletal Orthopedic Research and Education) is a 501(c)(3) nonprofit dedicated to improving musculoskeletal health worldwide. Through innovative research, advanced education, and impactful community outreach programs, MORE drives improvements in patient care, surgical outcomes, and healthcare delivery. MORE Foundation is accredited by the Arizona Medical Association to provide continuing medical education for physicians. MORE Foundation designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. For more information, go to View original content to download multimedia: SOURCE Healthcare Outcomes Performance Company
Associated Press
3 minutes ago
- Associated Press
Federal investigators demanded details on transgender patients from at least 1 hospital
When the U.S. Justice Department sought information from doctors and clinics that provide gender-affirming care for young transgender patients, officials weren't just asking for policies. They also demanded information about individual patients. Attorney General Pam Bondi announced in a statement July 9 that the department had sent more than 20 subpoenas to doctors and clinics that provide the care. The request represented an elevation in President Donald Trump's administration's effort to halt the medical treatment for transgender youth, even in states where it's legal. Bondi said the requests were part of investigations into 'healthcare fraud, false statements, and more.' No charges have been announced so far, but the probes have had a chilling impact on the availability of care. Specifics of the requests were not made public until a court filing in a separate lawsuit this week. Advocates say the requests are invasive and unnecessary. 'It turns doctor-patient confidentiality into government surveillance,' said Jennifer Levi, GLAD Law's senior director of Transgender and Queer Rights. At least one of the requests seeks names and social security numbers of patients The subpoena sent to Children's Hospital of Philadelphia on June 11 was included in a legal filing Monday in challenges from the states of Minnesota, Oregon and Washington to the administration's attempts to bar the treatment for patients under age 19. The 18-page document demanded an expansive list of documents be provided. Among them: Documents to identify 'by name, date of birth, social security number, address and parent/guardian information' patients who were prescribed puberty blockers or hormone therapy. The requests also covered personnel files for various categories of hospital employees, information about patient intake procedures and about which insurance billing codes the hospital used for gender-affirming care. The due date listed was July 9. It's not clear whether subpoenas sent to other providers were identical. Neither the hospital nor the Department of Justices responded to requests for comment on Thursday. Gender-affirming care has emerged as part of a political and legal battle Gender-affirming care includes a range of medical and mental health services to support a person's gender identity, including when it's different from the sex they were assigned at birth. It encompasses counseling, medications that block puberty and hormone therapy to produce physical changes as well as surgeries to transform chests and genitals, though those are rare for minors. Most major medical groups say access to the treatment is important for those with gender dysphoria and see gender as existing along a spectrum. While there's wide, if not universal, medical consensus, the political situation is contentious. Since 2021, at least 27 states have adopted laws restricting or banning the care for minors, and a U.S. Supreme Court ruling in June affirmed the states' right to have such policies, at least under certain conditions. Trump has signed one executive order defining sex as only male or female — and as unchangeable — and another that seeks to end federal funding of the care for patients under 19. He's also sought to bar transgender military service members and keep transgender athletes out of certain sports competitions. And the administration released a document that questions the standards of treatment for transgender youth and suggests relying solely on talk therapy rather than medical interventions. The investigation is one reason some clinics have halted the care At least eight major hospitals and hospital systems announced in July that they were stopping or restricting gender-affirming care, even though they're in states where it is not banned. Children's Hospital of Philadelphia is not among those that have announced they're curtailing care, though a place it has referred patients for surgeries — Penn Medicine — said in May that it would no longer perform them on patients under 19. A group of Democratic state officials across the country are suing the Trump administration, claiming it is intimidating healthcare providers to stop the care. GLAD Law's Levi said the investigation is just one of many factors that have led providers to change their policies. 'It's chilling,' she said.
Associated Press
3 minutes ago
- Associated Press
Marquis Who's Who Honors Albert K Chin, MD, as a Medical Technology Leader
UNIONDALE, NY / ACCESS Newswire / August 21, 2025 / Marquis Who's Who honors Albert K. Chin, MD, for his leadership in medical technology and as the founder of several medical device startups. With more than a decade of experience in his current position and a 35-year career in health care, Dr. Chin has significantly impacted the field, ensuring better patient outcomes through medical and technological advancements. Academic Foundations As a medical professional, Dr. Chin's work is supported by a robust education. He completed a bachelor's degree in mechanical engineering at the Massachusetts Institute of Technology in 1975 and a master's degree in mechanical engineering at Stanford University in 1976. He then earned a Medical Doctorate at the University of California, San Francisco's School of Medicine in 1983, followed by a residency in surgery at the University of Texas Southwestern Medical Center's Parkland Memorial Hospital in 1985. Professional Career and Entrepreneurship Soon after participating in a surgical residency, Dr. Chin entered the world of entrepreneurship. In 1989, he co-founded his first company, Origin Medsystems Inc., which became Guidant Cardiac Surgery in 1994 and Boston Scientific Cardiac Surgery in 2007. He served as vice president of research at Guidant and as chief innovation officer at Boston Scientific, continuing in that role a year later at Maquet Cardiovascular. Between 2009 and 2022, Dr. Chin co-founded Pavilion Medical Innovations LLC, Saphena Medical Inc., nVision Medical Inc., Cruzar Medsystems Inc., InnoVein Inc., TAS Medical Inc., PercAssist Inc., FemDx Medsystems Inc. and Orare Medsystems Inc. Today, he operates as chief innovative officer of the latter four companies. Achievements, Awards and Accolades One of Dr. Chin's most notable achievements relates to his work with PercAssist Inc., which helps patients in end-stage heart failure. He designed the technology: a balloon that compresses the left ventricle of the heart to increase a patient's cardiac output, acting as an artificial heart. The device is positioned outside the actual heart, so there is no need to anticoagulate patients, which can lead to bleeding and stroke complications. For his many contributions to medicine and medical technology, Dr. Chin has received numerous awards and accolades. He received the Ideals of Entrepreneurship Award from Stanford University's Emerging Entrepreneurs in Biomedical Technology program in 2007 and the Invented Here! Top Award from the Boston Patent Law Association in 2018. Additionally, he has been honored with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who. The Importance of Dedication Dr. Chin attributes his success to his dedication to continuous learning, a trait he developed through his education. He consistently pushes himself to think about his designs and nurtures his creativity to naturally generate ideas. His prolific creative output has resulted in 237 issued U.S. patents, a testament to his innovative thinking and problem-solving skills. In Dr. Chin's mind, dedication is key to realizing the final product. Moving forward, Dr. Chin's primary ambition is to continue designing medical devices. Committed to continuous improvement and refinement so patients can truly benefit from his work, he ensures each device is effective and fulfills its intended purpose. As medical science continues to advance, Dr. Chin is determined to maintain his status as a key innovator in the field. About Marquis Who's Who®: Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, Contact: Marquis Who's Who Uniondale, NY (844) 394 - 6946 [email protected] SOURCE: Marquis Who's Who press release
